Emerald Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Emerald Pharmaceuticals has a total of 59 patents globally, out of which 30 have been granted. Of these 59 patents, more than 88% patents are active. United States of America is where Emerald Pharmaceuticals has filed the maximum number of patents, followed by Canada and Hong Kong (S.A.R.). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Emerald Pharmaceuticals.

Emerald Pharmaceuticals was founded in the year 2017. The Company is a pharmaceutical company focused on nutritional and pharmaceutical products.

Do read about some of the most popular patents of Emerald Pharmaceuticals which have been covered by us in this article and also you can find Emerald Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Emerald Pharmaceuticals patent portfolio.

How many patents does the CEO of Emerald Pharmaceuticals have?

The CEO Jimmy DeMesa has 0 patent.

How many patents does Emerald Pharmaceuticals have?

Emerald Pharmaceuticals has a total of 59 patents globally. These patents belong to 966 unique patent families. Out of 59 patents, 52 patents are active.

How Many Patents did Emerald Pharmaceuticals File Every Year?

Emerald Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEmerald Pharmaceuticals Applications FiledEmerald Pharmaceuticals Patents Granted
202311
202222
202147
202062
201954
20187
201785
20163
20157
2014182

How many Emerald Pharmaceuticals patents are Alive/Dead?

Emerald Pharmaceuticals Patent Portfolio

 How Many Patents did Emerald Pharmaceuticals File in Different Countries?

Emerald Pharmaceuticals Worldwide Patent Filing

Countries in which Emerald Pharmaceuticals Filed Patents

CountryPatents
United States Of America8
Canada6
Hong Kong (S.A.R.)6
Australia5
Europe5
Japan4
Germany3
Spain3
Israel3
Russia2
India2
Brazil2
Denmark2
Austria2
Italy1
Mexico1

Where are Research Centres of Emerald Pharmaceuticals Patents Located?

R&D Centers of Emerald Pharmaceuticals

What Percentage of Emerald Pharmaceuticals US Patent Applications were Granted?

Emerald Pharmaceuticals (Excluding its subsidiaries) has filed 7 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Emerald Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Emerald Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Moore Patents2100.00%
Riverside Law Llp2100.00%
Think Ip P C Dba Prince Ip20%
Moore & Van Allen Pllc1100.00%

What are Emerald Pharmaceuticals key innovation segments?

What Technologies are Covered by Emerald Pharmaceuticals?

The chart below distributes patents filed by Emerald Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Emerald Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Emerald Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Emerald Pharmaceuticals?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.